BlackRock Fund Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BA
BIT
BlackRock Fund Advisors's DGX Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Quest Diagnostics (DGX) stake by 5.2% in Q4 2016, buying an estimated $13.9M and bringing the position to 3,248,788 shares worth $299M. The position accounts for 0.06% of the portfolio, ranked #398.
BlackRock Fund Advisors first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- BlackRock Fund Advisors held 3,248,788 shares of Quest Diagnostics worth $299M as of Q4 2016.
- BlackRock Fund Advisors bought 160,710 Quest Diagnostics shares in Q4 2016, an estimated $13.9M.
- Quest Diagnostics made up 0.06% of BlackRock Fund Advisors's portfolio in Q4 2016, its #398 holding.
- BlackRock Fund Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
- 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.